Dr. Amit N. Patel
Youngstown State University
Case Western Reserve UniversityMedicine - 1970
Baylor University Medical Center
University of Pittsburgh
Dr. Amit N. Patel is professor of surgery and chief of cardiac surgery at the University of Miami Health System. He was previously employed as a cardiothoracic surgeon at the Huntsman Cancer Institute in Salt Lake City, Utah where he also served as a researcher and associate professor at the University of Utah School of Medicine and director of the university’s Clinical Regenerative Medicine and Tissue Engineering department. Dr. Patel specializes in heart surgery, treating heart failure, and the treatment of cardiothoracic cancers like mesothelioma.
Dr. Patel received a bachelor’s degree in biological sciences from Youngstown State University in Youngstown, Ohio, and went on to pursue his master’s in immunophysiology from the same university. After receiving his medical degree from Case Western Reserve University, Dr. Patel completed an internship and residency in surgery at Baylor University Medical Center in Waco, Texas, and a fellowship in cardiothoracic surgery at the University of Pittsburgh. Dr. Patel is board certified and holds a special certificate from the American Board of Thoracic Surgery.
Dr. Patel’s professional interests include the surgery and treatment of a variety of heart and lung disorders, especially treatments that involve the use of stem cells. His research has shown how stem cell transplantation can be used to treat several kinds of heart disease, including cardiomyopathy and congestive heart failure. Another of Dr. Patel’s areas of expertise is minimally invasive thoracic and cardiovascular surgery, a relatively new set of surgical techniques that requires only a few small incisions in the patient’s body. Minimally invasive surgeries typically offer patients lower risk and a speedier recovery.
Mesothelioma treatment is also among Dr. Patel’s research interests, especially so-called “hyperthermic chemotherapy.” In this procedure, a warmed solution of anti-cancer drugs is washed over a patient’s tissue or organs where cancer cells are present. The treatment may be helpful in killing microscopic cancer cells left behind when a cancerous tumor is removed.
When serving as director of Clinical Regenerative Medicine and Tissue Engineering and the University of Utah, Dr. Patel was at the helm of two exciting new fields—regenerative medicine which seeks to treat patients by replacing damaged or diseases cells, tissue or organs with healthy cells and tissue engineering which involves the use of synthetic (man-made) materials to promote the growth of healthy tissue in the human body. Today, at the University of Miami Health System’s Sylvester Comprehensive Cancer Center, Dr. Patel continues to earn his reputation as a leader in the development of innovative therapies for cardiac and thoracic diseases.
“Allogenic endometrial regenerative cells: an 'Off the shelf solution' for critical limb ischemia?” — Journal of Translational Medicine, 2008
“Surgery remains the most effective treatment for Paget-Schroetter syndrome:50 years' experience” — Annals of Thoracic Surgery, 2008
“Changes in the expression pattern of mesenchymal and pluripotent markers in human adipose-derived stem cells.” — Cell Biology International, 2010
“Electrostimulation induces cardiomyocyte predifferentiation of fibroblasts.” — Biochemical and Biophysical Research Communications, 2008
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette